Diseases

T7431XS

Adult psychological abuse, confirmed, sequela

T7431XD

Adult psychological abuse, confirmed, subsequent encounter

T7631XA

Adult psychological abuse, suspected, initial encounter

T7631XS

Adult psychological abuse, suspected, sequela

T7631XD

Adult psychological abuse, suspected, subsequent encounter

J8482

Adult pulmonary Langerhans cell histiocytosis

T7421XA

Adult sexual abuse, confirmed, initial encounter

T7421XS

Adult sexual abuse, confirmed, sequela

T7421XD

Adult sexual abuse, confirmed, subsequent encounter

T7621XA

Adult sexual abuse, suspected, initial encounter

T7621XS

Adult sexual abuse, suspected, sequela

T7621XD

Adult sexual abuse, suspected, subsequent encounter

M061

Adult-onset Still's disease

G9344

Adult-onset leukodystrophy with axonal spheroids

Y07513

Adultcare center provider, perpetrator of maltreatment and neglect

T391X5A

Adverse effect of 4-Aminophenol derivatives, initial encounter

T391X5S

Adverse effect of 4-Aminophenol derivatives, sequela

T391X5D

Adverse effect of 4-Aminophenol derivatives, subsequent encounter

T446X5A

Adverse effect of alpha-adrenoreceptor antagonists, initial encounter

T446X5S

Adverse effect of alpha-adrenoreceptor antagonists, sequela

T446X5D

Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter

T365X5A

Adverse effect of aminoglycosides, initial encounter

T365X5S

Adverse effect of aminoglycosides, sequela

T365X5D

Adverse effect of aminoglycosides, subsequent encounter

T43625A

Adverse effect of amphetamines, initial encounter

T43625S

Adverse effect of amphetamines, sequela

T43625D

Adverse effect of amphetamines, subsequent encounter

T507X5A

Adverse effect of analeptics and opioid receptor antagonists, initial encounter

T507X5S

Adverse effect of analeptics and opioid receptor antagonists, sequela

T507X5D

Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter

T387X5A

Adverse effect of androgens and anabolic congeners, initial encounter

T387X5S

Adverse effect of androgens and anabolic congeners, sequela

T387X5D

Adverse effect of androgens and anabolic congeners, subsequent encounter

T464X5A

Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter

T464X5S

Adverse effect of angiotensin-converting-enzyme inhibitors, sequela

T464X5D

Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter

T38815A

Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter

T38815S

Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela

T38815D

Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter

T374X5A

Adverse effect of anthelminthics, initial encounter

T374X5S

Adverse effect of anthelminthics, sequela

T374X5D

Adverse effect of anthelminthics, subsequent encounter

T450X5A

Adverse effect of antiallergic and antiemetic drugs, initial encounter

T450X5S

Adverse effect of antiallergic and antiemetic drugs, sequela

T450X5D

Adverse effect of antiallergic and antiemetic drugs, subsequent encounter

T486X5A

Adverse effect of antiasthmatics, initial encounter

T486X5S

Adverse effect of antiasthmatics, sequela

T486X5D

Adverse effect of antiasthmatics, subsequent encounter

T440X5A

Adverse effect of anticholinesterase agents, initial encounter

T440X5S

Adverse effect of anticholinesterase agents, sequela

T440X5D

Adverse effect of anticholinesterase agents, subsequent encounter

T457X5A

Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter

T457X5S

Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela

T457X5D

Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter

T45515A

Adverse effect of anticoagulants, initial encounter

T45515S

Adverse effect of anticoagulants, sequela

T45515D

Adverse effect of anticoagulants, subsequent encounter

T476X5A

Adverse effect of antidiarrheal drugs, initial encounter

T476X5S

Adverse effect of antidiarrheal drugs, sequela

T476X5D

Adverse effect of antidiarrheal drugs, subsequent encounter

T506X5A

Adverse effect of antidotes and chelating agents, initial encounter

T506X5S

Adverse effect of antidotes and chelating agents, sequela

T506X5D

Adverse effect of antidotes and chelating agents, subsequent encounter

T367X5A

Adverse effect of antifungal antibiotics, systemically used, initial encounter

T367X5S

Adverse effect of antifungal antibiotics, systemically used, sequela

T367X5D

Adverse effect of antifungal antibiotics, systemically used, subsequent encounter

T386X5A

Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter

T386X5S

Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela

T386X5D

Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter

T466X5A

Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter

T466X5S

Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela

T466X5D

Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter

T372X5A

Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter

T372X5S

Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela

T372X5D

Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter

T371X5A

Adverse effect of antimycobacterial drugs, initial encounter

T371X5S

Adverse effect of antimycobacterial drugs, sequela

T371X5D

Adverse effect of antimycobacterial drugs, subsequent encounter

T451X5A

Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter

T451X5S

Adverse effect of antineoplastic and immunosuppressive drugs, sequela

T451X5D

Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter

T428X5A

Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter

T428X5S

Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela

T428X5D

Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter

T491X5A

Adverse effect of antipruritics, initial encounter

T491X5S

Adverse effect of antipruritics, sequela

T491X5D

Adverse effect of antipruritics, subsequent encounter

T394X5A

Adverse effect of antirheumatics, not elsewhere classified, initial encounter

T394X5S

Adverse effect of antirheumatics, not elsewhere classified, sequela

T394X5D

Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter

T45525A

Adverse effect of antithrombotic drugs, initial encounter

T45525S

Adverse effect of antithrombotic drugs, sequela

T45525D

Adverse effect of antithrombotic drugs, subsequent encounter

T382X5A

Adverse effect of antithyroid drugs, initial encounter

T382X5S

Adverse effect of antithyroid drugs, sequela

T382X5D

Adverse effect of antithyroid drugs, subsequent encounter

T483X5A

Adverse effect of antitussives, initial encounter

T483X5S

Adverse effect of antitussives, sequela

T483X5D

Adverse effect of antitussives, subsequent encounter

T468X5A

Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter